Stock Analysis

US Stocks Trading Below Estimated Value In February 2025

Published

As of February 2025, the U.S. stock market has experienced a mixed performance with recent declines following record highs for major indices like the S&P 500. This fluctuation presents an opportunity to explore stocks that may be trading below their estimated value, particularly in a market environment where identifying companies with strong fundamentals and potential for growth can be key to making informed investment decisions.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

NameCurrent PriceFair Value (Est)Discount (Est)
German American Bancorp (NasdaqGS:GABC)$39.82$74.9446.9%
Northwest Bancshares (NasdaqGS:NWBI)$12.65$24.4548.3%
Old National Bancorp (NasdaqGS:ONB)$23.97$45.8847.8%
Sandy Spring Bancorp (NasdaqGS:SASR)$32.99$64.5348.9%
Solaris Energy Infrastructure (NYSE:SEI)$29.34$57.3448.8%
Incyte (NasdaqGS:INCY)$71.38$135.0847.2%
Limbach Holdings (NasdaqCM:LMB)$83.35$160.2648%
Array Technologies (NasdaqGM:ARRY)$6.90$13.5048.9%
Open Lending (NasdaqGM:LPRO)$5.44$10.4948.2%
Haemonetics (NYSE:HAE)$63.45$121.9948%

Click here to see the full list of 161 stocks from our Undervalued US Stocks Based On Cash Flows screener.

Here we highlight a subset of our preferred stocks from the screener.

Light & Wonder (NasdaqGS:LNW)

Overview: Light & Wonder, Inc. is a cross-platform games company operating in the United States and internationally, with a market cap of $9.01 billion.

Operations: The company's revenue segments consist of Gaming at $2.05 billion, Igaming at $293 million, and Sciplay at $821 million.

Estimated Discount To Fair Value: 25.1%

Light & Wonder is trading at US$104.89, below its estimated fair value of US$140.05, indicating it is undervalued based on cash flows. Despite lower-than-market revenue growth forecasts, earnings are expected to grow 20.6% annually over the next three years, outpacing the US market's 14.5%. However, interest payments are not well covered by earnings and large one-off items impact financial results. Recent leadership changes may influence future product innovation and strategy alignment.

NasdaqGS:LNW Discounted Cash Flow as at Feb 2025

BeiGene (NasdaqGS:ONC)

Overview: BeiGene, Ltd. is an oncology company focused on discovering and developing cancer treatments globally, with a market cap of approximately $25.26 billion.

Operations: The company generates revenue from its pharmaceutical products segment, amounting to CN¥23.51 billion.

Estimated Discount To Fair Value: 35.4%

BeiGene, soon to be BeOne Medicines Ltd., is trading at US$244.20, significantly below its estimated fair value of US$377.86, highlighting its undervaluation based on cash flows. The company anticipates profitability within three years and forecasts a 66.96% annual earnings growth rate, surpassing market averages. Recent strategic collaborations in oncology research could enhance future revenue streams; however, existing debt obligations may pose challenges if not managed effectively amidst ongoing operational expansions and clinical trials.

NasdaqGS:ONC Discounted Cash Flow as at Feb 2025

Oracle (NYSE:ORCL)

Overview: Oracle Corporation provides products and services for enterprise information technology environments globally, with a market cap of approximately $507.70 billion.

Operations: Oracle's revenue is derived from three main segments: Hardware ($2.98 billion), Services ($5.27 billion), and Cloud and License ($46.68 billion).

Estimated Discount To Fair Value: 27.2%

Oracle is trading at US$176, significantly below its estimated fair value of US$241.89, indicating potential undervaluation based on cash flows. Despite a high debt level, Oracle's earnings and revenue are forecast to grow faster than the U.S. market at 15.7% and 11.9% annually, respectively. Recent product innovations in AI-powered cloud applications may enhance operational efficiencies and customer engagement, although managing debt remains crucial amid its expansion efforts and substantial fixed-income offerings totaling several billion dollars.

NYSE:ORCL Discounted Cash Flow as at Feb 2025

Turning Ideas Into Actions

Searching for a Fresh Perspective?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com